If you’ve received an organ transplant the Food and Drug Administration (FDA) wants to hear from you.  On September 27, 2016, FDA will hold its first to gain insight directly from patients about their experiences living with organ transplants and the medications they take to prevent organ rejection and manage related conditions.  This information will help FDA to consider issues important to patients when reviewing and considering approval of new therapies for transplant patients that may be developed in the future.  Input from these meetings will be incorporated into an official FDA report titled the Voice of the Patient.

If you are interested in participating live or via webcast here are the registration details: The public meeting will be held on September 27, 2016, from 9 a.m. to 5 p.m. Please register here for the meeting by September 20, 2016: http://organtransplantpfdd.eventbrite.com.

To keep up the momentum after the meeting, the National Kidney Foundation plans to submit written comments on this topic to FDA and we want to work with you to develop those comments. If you plan to attend the meeting either in person or via webinar, please email us at nkfadvocacy@kidney.org

You can learn more about the participation in this meeting and the questions you will be asked here: https://www.gpo.gov/fdsys/pkg/FR-2016-04-27/html/2016-09785.htm.

You can also find general information about the patient focused drug development initiative and the Voice of the Patient reports here: http://www.fda.gov/ForIndustry/UserFees/PrescriptionDrugUserFee/ucm368342.htm.